Viral Vaccine Vectors in Personalized Medicine

Project Information

VIVAVE

Grant agreement ID: 737592

DOI 10.3030/737592

Project closed

EC signature date 27 January 2017

Start date 1 February 2017

End date 31 December 2018

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 149 858,00

EU contribution € 149 858,00

Coordinated by

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

Author(s): Elham Beyranvand Nejad, Robert B. Ratts, Eleni Panagioti, Christine Meyer, Jennifer D. Oduro, Luka Cicin-Sain, Klaus Früh, Sjoerd H. van der Burg, Ramon Arens
Published in: Journal for ImmunoTherapy of Cancer, Issue 7/1, 2019, ISSN 2051-1426
Publisher: BMC
DOI: 10.1186/s40425-019-0500-9